Biopsafe ApS: Financial statements 2020
CVR: 33575505
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Biopsafe ApS (CVR 33575505) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,209,304 and a net result of DKK 219,043 compared with DKK 268,222 the year before. That is a decrease of 17.8% compared with the year before. Equity in the 2020 report amounted to DKK 4,000,280. The solvency ratio was 15.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 5,209,304
- Profit/Loss
- DKK 219,043
- Equity
- DKK 4,000,280
- Total Assets
- DKK 26,221,378
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 5.2 mio. | 219 t. | 4 mio. | 3 |
| 2019 | - | 6.3 mio. | 268 t. | 3.8 mio. | 1 |
| 2018 | - | 4.6 mio. | 39 t. | 3.5 mio. | 1 |
| 2017 | - | 557 t. | -2.2 mio. | 436 t. | 1 |
| 2016 | - | 1.9 mio. | 27 t. | 167 t. | - |
Official annual report
How creditworthy is Biopsafe ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biopsafe ApS has published its annual report for 2019. Gross profit came to DKK 6,339,646, and the net result was DKK 268,222.
About Biopsafe ApS
Biopsafe ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2011. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named AX-LAB INNOVATION ApS. The management consists of Anne Lykke Gade. The board consists of Anders Dahlberg. The company is owned by MedCap AB (publ). The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 14,274,000 and a net result of DKK 6,231,000 compared with DKK 4,087,000 the year before. Equity in the 2025 report amounted to DKK 11,231,000.